Motley Fool  35 min ago  Comment 
Valeant has lost more than 90% of its value since August, and further downside may be in the cards.
The Economic Times  6 hrs ago  Comment 
JB Chemicals and Pharmaceuticals plans to appeal the orders passed by National Green Tribunal against the company's Panoli bulk drugs plant before the higher judiciary.
Motley Fool  May 17  Comment 
Even though the market fell sharply today, these stocks rose. Find out why.
Motley Fool  May 17  Comment 
There's good news for the biotech's Zika virus vaccine efforts from non-human primate testing.
Clusterstock  May 17  Comment 
ZURICH (Reuters) - Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer medicines and the second on other drugs, it said on Tuesday. It also said David Epstein, division head and chief executive of...
Wall Street Journal  May 17  Comment  May 17  Comment 
Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis Novartis International AG / Novartis focuses Pharmaceuticals...
Reuters  May 17  Comment 
* Acquired through second closing of non-brokered private placement 1.5 million common shares in capital of fennec pharmaceuticals
MarketWatch  May 17  Comment 
Catalyst Pharmaceuticals Inc. said Tuesday it will lay off 30% of its workforce, effective immediately, in an effort to conserve cash. The developer of neuromuscular disease treatments said the job cuts, which affects employees from its...
Forbes  May 17  Comment 
Valeant Pharmaceuticals is planning on paying its top brass multi-million dollar bonuses as a reward for sticking with the embattled drugmaker.


This is a list of sub-industries in the pharmaceuticals industry, and a list of their member companies

Drug Delivery

Drug Manufacturers - Major

Drug Manufacturers - Other

Drug Related Products


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki